Afamelanotide Completed Phase 3 Trials for Polymorphic Light Eruption (PLE)

IndicationsStatusPurposePhase
CompletedNot Available3
clinicaltrials.gov IdentifierTitleDrugs
NCT00472901Phase III Trial of CUV1647 in Polymorphic Light Eruption (PLE)